Intech Investment Management LLC Acquires 14,645 Shares of Ingevity Corporation $NGVT

Posted by on Jun 5th, 2026

Intech Investment Management LLC grew its holdings in Ingevity Corporation (NYSE:NGVT – Free Report) by 106.6% during the fourth quarter, Holdings Channel reports. The firm owned 28,389 shares of the company’s stock after acquiring an additional 14,645 shares during the quarter. Intech Investment Management LLC’s holdings in Ingevity were worth $1,680,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in NGVT. Global Retirement Partners LLC acquired a new stake in Ingevity during the fourth quarter worth approximately $27,000. Geneos Wealth Management Inc. increased its holdings in Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares in the last quarter. Headlands Technologies LLC acquired a new position in Ingevity in the second quarter valued at approximately $46,000. CIBC Private Wealth Group LLC acquired a new position in Ingevity in the third quarter valued at approximately $62,000. Finally, Assetmark Inc. bought a new position in shares of Ingevity during the 4th quarter worth approximately $86,000. Institutional investors own 91.59% of the company’s stock.

Ingevity Trading Down 1.3%

Shares of Ingevity stock opened at $66.10 on Friday. The stock has a market capitalization of $2.30 billion, a PE ratio of -18.62 and a beta of 1.18. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29. The stock has a 50 day moving average price of $71.67 and a two-hundred day moving average price of $66.34. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42.

Ingevity (NYSE:NGVT – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same period in the prior year, the firm earned $1.01 earnings per share. Ingevity’s revenue for the quarter was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, equities analysts anticipate that Ingevity Corporation will post 5.05 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president owned 7,202 shares in the company, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.88% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on NGVT. Jefferies Financial Group reaffirmed a “buy” rating and set a $82.00 price objective on shares of Ingevity in a research report on Thursday, February 26th. Wells Fargo & Company increased their target price on shares of Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. BMO Capital Markets reaffirmed an “outperform” rating and issued a $83.00 price target on shares of Ingevity in a research note on Monday, March 2nd. Finally, Wall Street Zen upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $80.00.

View Our Latest Stock Analysis on Ingevity

Ingevity Profile

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Stories

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.